On 20 May 2019, the law changing provisions regarding providing scientific and technical advice by the Federal Agency for Medicines and Health Products and regarding the financing of the Federal Agency for Medicines and Health Products (financing law of 2019) has been published in the Belgian Official Gazette. The new law changes a number of aspects of the function and financing of the Federal Agency for Medicines and Health Products (FAMHP).
The law dated 11 March 2018 regarding the financing of the Federal Agency for Medicines and Health Products (financing law of 2018) brought most of the provisions for the financing of the FAMHP together in one law. It also brought a great deal of changes to the provisions with it.
The financing law of 2019 revises the financing law of 2018 on various points, namely:
1. linguistic and technical corrections;
2. revision of the fees or percentages of a number of fees and contributions;
3. introduction of a number of new fees.
You can read more about the specific changes in this letter.
More information
General page on fees to the FAMHP.